Literature DB >> 1314453

Cell-specific envelope glycosylation distinguishes FIV glycoproteins produced in cytopathically and noncytopathically infected cells.

M L Poss1, S W Dow, E A Hoover.   

Abstract

Feline immunodeficiency virus (FIV) infection induces syncytium formation and cell death in primary feline astrocyte cultures but persistently and noncytopathically infects Crandell feline kidney cells (CrFK). Because viral envelope glycoproteins are implicated in cell fusion events we evaluated the astrocyte-produced FIV surface glycoprotein for properties that might distinguish it from that produced in CrFK cells. The surface glycoprotein from astrocytes migrated faster on SDS-PAGE and contained more Endo H-sensitive oligosaccharides than that from CrFK, although the precursor and deglycosylated envelope glycoproteins from both cells were the same size. Castanospermine treatment of infected astrocytes, which blocks glucose trimming from oligosaccharide side chains of glycoproteins, both obliterated the mobility difference between astrocyte- and CrFK-produced FIV surface glycoproteins and prevented syncytium in infected astrocyte cultures. These results demonstrate the importance of the infected cell type in viral envelope protein glycosylation and implicate cell type-specific carbohydrate structures on retroviral glycoproteins as mediators of cell fusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314453     DOI: 10.1016/0042-6822(92)90731-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Correlation of specific virus-astrocyte interactions and cytopathic effects induced by ts1, a neurovirulent mutant of Moloney murine leukemia virus.

Authors:  E Shikova; Y C Lin; K Saha; B R Brooks; P K Wong
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

2.  Microglial infection by a neurovirulent murine retrovirus results in defective processing of envelope protein and intracellular budding of virus particles.

Authors:  W P Lynch; W J Brown; G J Spangrude; J L Portis
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

3.  In vivo monocyte tropism of pathogenic feline immunodeficiency viruses.

Authors:  S W Dow; C K Mathiason; E A Hoover
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 4.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.

Authors:  L S Sawyer; M T Wrin; L Crawford-Miksza; B Potts; Y Wu; P A Weber; R D Alfonso; C V Hanson
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development.

Authors:  J Johnston; C Power
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Differential cell killing by lymphomagenic murine leukemia viruses occurs independently of p53 activation and mitochondrial damage.

Authors:  Suparna Nanua; Fayth K Yoshimura
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Mink epithelial cell killing by pathogenic murine leukemia viruses involves endoplasmic reticulum stress.

Authors:  Suparna Nanua; Fayth K Yoshimura
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 9.  Haematological disorders associated with feline retrovirus infections.

Authors:  M L Linenberger; J L Abkowitz
Journal:  Baillieres Clin Haematol       Date:  1995-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.